Great question, our training data involves thousands of ECGs to validate the software performance of the algorithm itself. As far as in-human data, 100 patients is well-powered for Phase I software validation, in preparation for our upcoming prospective clinical trial (Phase II). These results are hot off the press so we don't have a public link yet - more to come!